You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV Antibodies

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in Worldwide (Saline, Lefitolimod, 3BNC117 and 10-1074)

Active, not recruiting
  • HIV-1-infection
  • Salt Lake City, Utah
  • +7 more
Mar 30, 2022

HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)

Active, not recruiting
  • HIV-1 Infection
  • Oral Lenacapavir
  • +3 more
  • Los Angeles, California
  • +22 more
Nov 4, 2022

Hiv Trial in Denmark, United Kingdom (Romidepsin, 3BNC117, Antiretrovirals)

Active, not recruiting
  • Hiv
  • Aalborg, Denmark
  • +6 more
Sep 3, 2021

European Pregnancy and Paediatric Infections Cohort

Recruiting
  • Sars-Cov2 Antibodies in Children and Adolescents Living With HIV
    • Brussels, Belgium
    • +6 more
    Sep 22, 2022

    Antibodies Production After Covid-19 Vaccination Among Medical

    Recruiting
    • Covid19
    • +2 more
    • Laboratory Samples
    • San Juan, Puerto Rico
      Auxilio Mutuo Cancer Center
    Mar 2, 2021

    HIV, Herpes Simplex Infections Trial in Providence (MB66, Placebo Film)

    Completed
    • HIV
    • Herpes Simplex Infections
    • Providence, Rhode Island
      The Miriam Hospital
    Apr 19, 2021

    Hiv, HIV/AIDS, HIV Trial in San Francisco, Boston, Minneapolis (N-803 and bNAbs, haNK™ Cells)

    Withdrawn
    • Hiv
    • +5 more
    • N-803 and bNAbs
    • haNK™ Cells
    • San Francisco, California
    • +2 more
    Oct 21, 2020

    HIV Trial in Boston (PGDM1400/Placebo (3mg/kg IV), PGDM1400/Placebo (10mg/kg IV), PGDM1400/Placebo (30mg/kg IV))

    Completed
    • HIV Infections
    • PGDM1400/Placebo (3mg/kg IV)
    • +7 more
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Sep 11, 2020

    HIV-1-infection Trial in Worldwide (3BNC117-LS-J, 10-1074-LS-J, Combination 3BNC117-LS-J and 10-1074-LS-J)

    Unknown status
    • HIV-1-infection
    • 3BNC117-LS-J
    • +6 more
    • Boston, Massachusetts
    • +8 more
    Dec 11, 2020

    Australian Hepatitis and Risk Survey in Prisons

    Recruiting
    • Hepatitis C
    • +2 more
    • Point-of-care hepatitis C antibody test
    • +5 more
    • Hume, Australian Capital Territory, Australia
    • +23 more
    Apr 20, 2023

    Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)

    Not yet recruiting
    • HIV Seropositivity
    • +2 more
    • HIV Ag +Ab Assay Kit (Sysmex)
    • (no location specified)
    Aug 1, 2023

    HIV Infection, Monoclonal Antibody, Human, HIV Antibodies Trial run by the NIAID (VRC-HIVMAB060-00-AB)

    Completed
    • HIV Infection
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    Pertussis Immunization During Pregnancy & HIV Infection

    Completed
    • Immunization; Infection
    • +3 more
    • TDaP
    • Brussels, Belgium
    • +1 more
    Sep 29, 2022

    HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

    Active, not recruiting
    • HIV-1-infection
    • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
    • Amsterdam, Noord-Holland, Netherlands
      Amsterdam University Medical Centers, location AMC
    Jan 31, 2023

    HIV-1 Infection, Neutralizing Antibody, Monoclonal Antibody Trial run by the NIAID (VRC-HIVMAB060-00-AB)

    Completed
    • HIV-1 Infection
    • +4 more
    • VRC-HIVMAB060-00-AB
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

    Suspended
    • HIV Infections
    • BG505 MD39.3 mRNA
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Feb 1, 2023

    Prevention of HIV Infection, HIV Antibodies, Monoclonal Antibody, Human Trial run by the NIAID (VRC-HIVMAB080-00-AB (VRC01LS),

    Completed
    • Prevention of HIV Infection
    • +3 more
    • VRC-HIVMAB080-00-AB (VRC01LS)
    • VRC-HIVMAB060-00-AB (VRC01)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    HIV Trial (Low dose KL-HIV-Tri01, Middle dose KL-HIV-Tri01, High dose KL-HIV-Tri01)

    Not yet recruiting
    • HIV Infections
    • Low dose KL-HIV-Tri01
    • +2 more
    • (no location specified)
    Nov 5, 2023

    HIV-1-infection Trial in Puerto Rico, United States (TMB-365/TMB-380)

    Recruiting
    • HIV-1-infection
    • San Francisco, California
    • +6 more
    Oct 25, 2022

    HIV Trial in Rochester, Nashville, Seattle (HIV-1 C4-V3 Polyvalent Peptide Vaccine)

    Completed
    • HIV Infections
    • HIV-1 C4-V3 Polyvalent Peptide Vaccine
    • Rochester, New York
    • +2 more
    Oct 27, 2021

    HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)

    Withdrawn
    • HIV Infection
    • Analytical Treatment Interruption + bNAbs infusion
    • Milan, Lombardy, Italy
    • +3 more
    Aug 2, 2022

    Healthy Trial (763SIP8/MPLA-5 vaccine)

    Not yet recruiting
    • Healthy
    • 763SIP8/MPLA-5 vaccine
    • (no location specified)
    Mar 15, 2023

    HIV-1-infection Trial in London (ConM SOSIP, EDC ConM SOSIP, ConS UFO)

    Active, not recruiting
    • HIV-1-infection
    • ConM SOSIP
    • +4 more
    • London, United Kingdom
      NIHR Imperial Clinical Resarch Facility
    Jul 25, 2022

    HIV Infections in Transgender and Non-binary People in Flanders

    Recruiting
    • HIV Infections
    • Survey on socio-demographic variables and healthcare-seeking, sexual and drug-using behaviour
    • Ghent, Oost-Vlaanderen, Belgium
      University Hospital, Ghent
    Mar 9, 2022

    HIV Trial in Worldwide (PGDM1400LS (5mg/kg, IV), PGDM1400LS (20mg/kg, IV), PGDM1400LS (20mg/kg, SC))

    Recruiting
    • HIV Infections
    • PGDM1400LS (5mg/kg, IV)
    • +16 more
    • San Francisco, California
    • +13 more
    Aug 12, 2022